Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Vanini

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Plos Neglected Tropical Diseases|November 18, 2015
Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the CystsLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
Journal of Translational Medicine|June 27, 2021
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infectionElisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2021
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patientsAlessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
Plos Pathogens|June 16, 2016
Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful TreatmentSimone A Joosten, Krista E van Meijgaarden, Franca Del Nonno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 12, 2018
First description of agonist and antagonist IP-10 in urine of patients with active TBLinda Petrone, Vincent Bondet, Valentina Vanini, et al.
The Journal of Infection|April 3, 2012
IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic countryValentina Vanini, Elisa Petruccioli, Cristiana Gioia, et al.
The Journal of Infection|December 3, 2014
IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activityLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
The Journal of Infection|April 15, 2019
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseasesTeresa Chiacchio, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2023
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfectionSaeid Najafi-Fard, Alessandra Aiello, Assunta Navarra, et al.
Frontiers in Immunology|November 12, 2024
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosisSaeid Najafi-Fard, Chiara Farroni, Linda Petrone, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Plos Neglected Tropical Diseases|November 18, 2015
Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the CystsLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
Journal of Translational Medicine|June 27, 2021
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infectionElisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2021
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patientsAlessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
Plos Pathogens|June 16, 2016
Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful TreatmentSimone A Joosten, Krista E van Meijgaarden, Franca Del Nonno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 12, 2018
First description of agonist and antagonist IP-10 in urine of patients with active TBLinda Petrone, Vincent Bondet, Valentina Vanini, et al.
The Journal of Infection|April 3, 2012
IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic countryValentina Vanini, Elisa Petruccioli, Cristiana Gioia, et al.
The Journal of Infection|December 3, 2014
IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activityLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
The Journal of Infection|April 15, 2019
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseasesTeresa Chiacchio, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2023
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfectionSaeid Najafi-Fard, Alessandra Aiello, Assunta Navarra, et al.
Frontiers in Immunology|November 12, 2024
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosisSaeid Najafi-Fard, Chiara Farroni, Linda Petrone, et al.
Pageof 7